In conclusion, our findings suggest that TIGD1 holds significant potential as a diagnostic and prognostic marker in lung cancer, offering a promising target for the development of targeted therapies, including those based on immunotherapy and specific drugs. Here, TIGD1 is linked to lung cancer.